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Prevalence rates of HIV infection in KwaZulu-Natal are high, with a significant amount of those 
infected being women of reproductive age. A diagnosis of HIV infection has been associated with an 
increased risk for the development of depression. Antenatal depression is a serious health concern, as 
it has the potential to cause wide-reaching adverse consequences for both mother and unborn child. 
Thus the objective of this study is to compare depressive scores between newly diagnosed HIV-
infected and uninfected pregnant women in KwaZulu-Natal to elucidate any association between a 
new diagnosis of HIV infection and the development of antenatal depression. 
 
Methods 
102 newly HIV tested Black African pregnant women were recruited from antenatal clinics at two 
regional hospitals; further stratified into two cohorts based on HIV status (HIV-infected: n=40; HIV-
uninfected: n=62). Women’s sociodemographic and clinical data were recorded, before being 
assessed for depression using an IsiZulu version of the Edinburgh Depression Scale. 
 
Results 
Of the sample, 9.8% suffered from depression. Prevalence rates of antenatal depression did not differ 
significantly between the HIV-infected and uninfected cohorts (p=0.79). A diagnosis of HIV 
infection (p<0.0001) and maternal age (p=0.03) are risk factors for antenatal depression. 
Unemployment (p=0.09) is a borderline risk factor for the development of antenatal depression.  
 
Conclusion 
Prevalence rates of depression are low in our sample. A new diagnosis of HIV infection in pregnancy 
places women at an increased risk for the development of antenatal depression. Younger age and 































It is projected that by 2030, depression and Human Immunodeficiency Virus (HIV) infection will be 
two of the world’s foremost contributors of disability (Mathers and Loncar, 2006). A diagnosis of 
HIV infection is associated with a surge in depressive symptoms (Psaros et al, 2009; Manikkam and 
Burns, 2012). Pregnancy is commonly associated with depression and is a serious health concern, as 
it impacts on both maternal, and child development and well-being (Bunevicius et al., 2009).  
 
A new diagnosis of HIV infection increases this risk of depression in pregnancy (Ramirez-Avila et 
al., 2012). The consequences of antenatal depression in HIV-infected women, especially those who 
have not initiated anti-retroviral treatment, include poor birth outcomes, such as miscarriage and 
prematurity, as well as increased development of postnatal depression (Marcus, 2009), and an 
increase in disease progression, thus affecting both mother and child. Hence studies that determine if 
HIV-infected pregnant women are more at risk for developing depression than HIV-uninfected 
pregnant women are urgently warranted. Furthermore, to the best of our knowledge there are very 
few studies of depression in HIV-infected pregnant women carried out in KwaZulu-Natal. This study 
will compare the depressive scores between newly diagnosed HIV-infected pregnant women and 
HIV-uninfected pregnant women using the Edinburgh Depression Scale (EDS).  
 
1.2 HIV 
1.2.1 History/origin of HIV Infection 
Acquired Immune Deficiency Syndrome (AIDS) is caused by the progression of HIV infection 
(Sharp and Hahn, 2011). Since its first diagnosis in 1981, over 30 million people have died from 
AIDS related issues (UNAIDS and WHO, 2005). The two species: HIV-1 and HIV-2, developed on 
the African continent as zoonotic infections in primate hosts, emanating from a lentivirus known as 
simian immunodeficiency virus (SIV) (Sharp and Hahn, 2011). SIV infection is transmitted sexually 
among primates, however, in contrast with HIV, the primates themselves do not become immune 
deficient (Wessels, 2014). The butchering and the consumption of the infected primates by humans is 
thought to be the source of first human infections (Peeters et al., 2002). The contagion has since 
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spread worldwide at an unprecedented rate through sexual contact with infected persons, via infected 
body substances that come into contact with the bloodstream, broken skin or mucous membranes, as 
well as via mother to child transmission (HSRC, 2005).  
 
1.2.2 Epidemiology 
HIV infection has become one of the world’s most dire health and developmental challenges. In 
2001, globally 29.8 million people were living with HIV infection. By the end of 2012, an estimated 
35.3 million people were infected globally, of which 32 million were adults and 3.3 million were 
children under the age of 15 years (UNAIDS, 2013). According to latest global estimates from 
UNAIDS (2015), in 2014 there were a total of 36.9 million infected people, with an estimated 2.0 
million new infections being reported in that year alone (5600 new infections daily). These statistics 
highlight the global impact of HIV; however there are specific regions of the world which are 
disproportionately impacted by this disease. While new cases have been reported in all regions of the 
world, the HIV/AIDS epidemic has far-reaching effects in low and middle income countries (L’akoa 
et al., 2013), with more than 90% of HIV-infected individuals living in the developing world 
(Wessels, 2014).  
 
1.2.3 The South African context 
Sub-Saharan Africa remains the most severely affected region by the HIV infection pandemic, 
accounting for approximately 70% of people living with HIV infections globally (UNAIDS, 2015). 
With nearly one in every twenty adults living with HIV, Southern African countries have the highest 
rates of HIV infection worldwide (Wessels, 2014). In this region, South Africa has been significantly 
impacted by the HIV/AIDS epidemic, with an estimated 11.2% of the population being infected with 
HIV (Statistics South Africa, 2015). Being home to the highest number of people living with HIV 
infection in the world, estimated at approximately 6.19 million in 2015 (Statistics South Africa, 
2015), this country is considered the epicenter of the global HIV pandemic. Additionally research 
indicates that the impact of HIV on mortality in South Africa has been significant, with AIDS 





1.2.4 Women and HIV infection 
Moreover, women represent approximately half (51%) of adults living with HIV infection and nearly 
a quarter of new HIV infections worldwide (Centers for Disease Control and Prevention, 2011); with 
majority occurring in women of reproductive age. With prevalence rates of the virus being three 
times higher among young women than men of the same age  (UNFPA, 2014), it is not surprising that 
globally, HIV infection is one of the most prominent contributors of maternal death in women of 
reproductive age (Crompton, 2013). The majority of the estimated 17.4 million women living with 
HIV globally are from Sub-Saharan Africa, and are of reproductive age (WHO, 2014). According to 
Chi et al. (2013), around 1.5 million HIV-infected women in Sub-Saharan Africa become pregnant 
each year. In South Africa alone, approximately one-fifth of women in their reproductive ages are 
HIV-infected (Statistics South Africa, 2015) and recent HIV prevalence rates indicate that up to 
22.8% of pregnant women are HIV-infected (Statistics South Africa, 2015). In KwaZulu-Natal 
province alone, the antenatal rate of HIV infection is approximately 30% (Department of Health, 
2012).  
 
1.2.5 HIV diagnosis in pregnancy 
Although global HIV testing capacity has increased over time, enabling more individuals to ascertain 
their HIV status, nearly half of all infected individuals are still unaware of this status. In South Africa 
it is a standard of care practice for all women attending antenatal facilities to be HIV tested. Hence 
many women will test for HIV infection for the first time during their pregnancy. A challenge of this 
diagnosis is that many women will experience serious maternal distress with resultant adverse foetal 
outcome (Bunevicius et al., 2009). 
 
1.3 Depression 
1.3.1 HIV diagnosis and depression 
A diagnosis of HIV infection is accompanied by psychological distress (Kotze et al., 2013), with 
depression being the most common complication (Tate et al., 2003). Spies and Seedat (2014) found 
that depression is highly prevalent in an HIV-infected population, with HIV-infected individuals 
being almost twice as likely to be depressed when compared to HIV uninfected individuals (Ciesla 
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and Roberts, 2001). Depression among these individuals have serious implications for disease 
progression, as well as quality of life (Bonacquisti et al., 2014).  
 
Suffering from depression should not be confused with everyday bouts of sadness. According to 
criteria displayed by the Diagnostic and Statistical Manual for Mental Disorder fifth edition (DSM-
V) (APA, 2013), major depression is defined as a cluster of symptoms, covering changes in an 
individual’s cognition, affect and behaviour that negatively impacts their daily functioning 
(educational, social or occupational), which lasts more than two weeks. These symptoms include a 
pervasive sad or depressed mood, suicidal behaviour, feelings of worthlessness or guilt, difficulty 
with concentration, loss of energy, a decreased interest in almost all activities, psychomotor 
retardation or agitation, changes in sleeping patterns (insomnia or hypersomnia), as well as changes 
in weight (excessive weight gain or loss) or changes in appetite (overeating or undereating). For a 
diagnosis of major depression to be made, at least five of the above mentioned symptoms must be 
present daily for more than two weeks (APA, 2013). 
 
1.3.2 Depression in HIV-infected pregnant women 
Pregnancy is not always a time of emotional well-being, as more than a third of pregnant women 
experience substantial depressive symptoms (Manikkam and Burns, 2012), which have been 
attributed to various psychosocial and biological factors. This highlights the fact that pregnancy on 
its own carries a risk of depression particularly in the postpartum period without the added burden of 
a HIV infection diagnosis.  
 
The knowledge and timing of such a diagnosis can have an effect on psychiatric co-morbidities such 
as depression (Kapetonovic et al., 2014). Studies show that women who are recently diagnosed with 
HIV infection are at a higher risk of being diagnosed with depression (Ramirez-Avila et al., 2012; 
Olley et al., 2004). In Zambia, women who knew their status before becoming pregnant were found 
to be less likely to develop depressive symptoms compared to those diagnosed during pregnancy 
(Kwalomota et al., 2002). This may be attributed to the relatively short time period for adjustment to 
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such a diagnosis, the stigma attached to being pregnant whilst HIV-infected (Psaros et al., 2009), as 
well as the fear of placing the unborn child at risk of HIV infection (Whetten et al., 2008).  
 
Moreover, the impact of a chronic illness, such as that of HIV leads to extensive psychosocial 
challenges for the individual, which places the mother at a risk of depression during pregnancy 
(Manikkam and Burns, 2012). In contrast, other studies conclude that there is no significant 
difference in the rate of depression between a HIV-infected versus HIV-uninfected antenatal 
population (Rochat et al., 2006).  
 
1.3.3 Consequences of antenatal depression in the HIV-infected and uninfected population 
Depression in the general population is a considerable health concern. Antenatal depression is even 
more so, having the potential to compromise the wellbeing of both mother and child (Psaros et al., 
2009). These consequential adverse outcomes include obstetric complications such as miscarriage, 
preterm labour and growth delays (Alder et al., 2007). In addition to the numerous physiological 
effects that antenatal depression is associated with, depression during pregnancy may also affect a 
mother’s cognitive functioning levels that alter her decision-making capabilities (Manikkam and 
Burns, 2012). In the case of HIV-infected pregnant women, this impacts the mother’s attendance of 
antenatal facilities as well as a negative adherence of a physician’s course of therapy (Natamba et al., 
2014), which may aggravate disease progression (Antelman et al., 2007), invariably increasing the 
risk of adverse maternal and infant outcomes (Field, 2011).  
 
Antenatal depression is an independent risk factor for the development of postnatal depression 
(Milgrom et al., 2008; Rochat et al., 2013), increasing the risk of development by an estimated 50-
60% (Manikkam and Burns, 2012). However, given that traditional forms of antenatal health care 
with its primary focus placed on physiological health, whilst generally overlooking the psychological 
health of patients, antenatal depression was regularly underdiagnosed, thus giving considerable 
attention to depression in the postnatal phase instead (Alder et al., 2011). It is only during the past 
decade that studies focusing on psychological morbidity among the antenatal population became 
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more common, with studies indicating that prevalence rates of antenatal depression are higher than 
that of postnatal depression (Bennett et al., 2004).  
 
In low socio-economic countries such as South Africa (47%), Pakistan (48%) and India (53%), 
higher rates of antenatal depression are more evident (Rochat et al., 2013; Shah et al., 2011; Gausia 
et al., 2009), as compared to the prevalence rates recorded in more developed settings, such as 4% in 
Hong Kong (Lee et al., 2004). However, as 50% of cases of antenatal depression are undetected 
(Alder et al., 2011) these numbers are probably significantly higher. 
 
1.3.4 Screening for antenatal depression  
There is an urgent need to establish whether HIV-infected antenatal women are at a greater risk of 
depression than HIV-uninfected antenatal women.  
 
Screening is the most widely utilised technique for the early detection of infections and disease. It 
involves the application of tests, examinations or other procedures that can be promptly applied for 
the early identification of unrecognised disease or defect (Shah, 1998). However, screening is just a 
preliminary step in the detection of probable disease and is not a diagnostic instrument (Shah, 1998).  
 
Screening tools for depression were developed as rating scales, allocating numerical values to a range 
of questions or statements based on the individuals complex feelings, behaviour and affect. However, 
screening for antenatal depression is not a straightforward task, given that some symptomology of 
depression may overlap with that of the somatic complaints of pregnancy itself (Psaros et al., 2009). 
The need for determining if there is a significant difference in the rate of depression between HIV-
infected and uninfected pregnant women is highlighted by the fact that depression has been listed as 
one of the two leading causes of death in antenatal and postnatal women in the United Kingdom 
(Lewis, 2004). Although a ‘gold standard’ screening tool for depression in the antenatal population 
has not yet to be identified, studies have begun to evaluate the use of several depression screening 
tools that have been developed or modified including that of the Edinburgh Depression Scale 
(Murray and Cox, 1990).  
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1.3.4.1 The Edinburgh Depression Scale  
This scale was originally established in 1987 and named the Edinburgh Postnatal Depression Scale 
(Cox et al., 1987), as it was developed as a screening tool for postpartum depression. It is one of 
most extensively used and researched screening tool amongst pregnant women (Boyd et al., 2005). It 
has also been validated as a depression screening tool for non-pregnant individuals (Becht et al., 
2001), giving rise to a new nomenclature: the Edinburgh Depression Scale (EDS) (Murray and Cox, 
1990). This is a 10-item self-rating depression scale that relates to the individuals depressive 
symptoms during the week prior to administration. The EDS has been validated in both postnatal and 
antenatal Black South African women (Lawrie et al., 1998; De Bruin et al., 2004; Manikkam and 
Burns, 2012), and specifically amongst newly diagnosed HIV-infected antenatal women in South 
Africa (Rochat et al., 2006).  
 
1.4 Study aim and objectives 
Numerous studies have concluded that major depression is highly prevalent among the HIV-infected 
population (Ciesla and Roberts, 2001; Manikkam and Burns, 2012; Spies and Seedat, 2014). 
Unfortunately there still remains conflicting reports on the impact of a diagnosis of HIV infection on 
the development of antenatal depression. Whilst some studies have found evidence of an HIV 
diagnosis increasing the risk of antenatal depression, others report that it had no significant impact on 
the prevalence of antenatal depression. However, given the serious consequences of antenatal 
depression in HIV-infected women, the study aim and objectives are as follows: 
1.4.1 Aim of the study: To compare depressive scores between newly diagnosed HIV-infected and 
uninfected pregnant women using the Edinburgh Depression Scale (EDS) in KwaZulu-Natal, South 
Africa.  
 
1.4.2 Specific objectives: 
1. To administer and assess the Edinburgh Depression Scale in newly diagnosed HIV-infected and 
uninfected pregnant women. 
2. To compare depressive scores between the infected and uninfected cohort. 
3. To assess intra-group depressive scores with patient demographics. 
 
With the information obtained from the study, we will be able to aid proper diagnosis, management 
and treatment, thus contributing to an improvement in the quality of life of the depressed mother and 
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infant. Conducting this study will essentially be a first step in creating a benchmark for screening for 
depression in the pregnant population, as well in HIV associated pregnancies; thereby facilitating 
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Background: Prevalence rates of HIV infection in KwaZulu-Natal are high, with a 
significant amount of those infected being women of reproductive age. A diagnosis of 
HIV infection has been associated with an increased risk for the development of 
depression. Antenatal depression is a serious health concern, having the potential to 
cause wide-reaching adverse consequences for both mother and unborn child. 
Aim: To compare depressive scores between newly diagnosed HIV-infected and 
uninfected pregnant women. 
Setting: Antenatal clinics at two regional hospitals in KwaZulu-Natal, South Africa 
Methods: A cross-sectional questionnaire based analysis of 102 newly HIV tested 
Black African pregnant women (HIV-infected: n=40; HIV-uninfected: n=62) was 
conducted. Women’s sociodemographic and clinical data were recorded, before being 
assessed for depression using an IsiZulu version of the Edinburgh Depression Scale. 
Results: Of the total study population, 9.8% suffered from depression, irrespective of 
HIV status. Prevalence rates of antenatal depression did not differ significantly between 
the HIV-infected and uninfected cohorts (p=0.79). A new diagnosis of HIV infection 
(p<0.0001) and maternal age (p=0.03) were risk factors for antenatal depression. 
Unemployment was a borderline risk factor (p=0.09) for the development of antenatal 
depression. 
Conclusion: Prevalence rates of depression were low. Knowledge of a new diagnosis 
of HIV infection at the first antenatal visit places women at an increased risk for the 
development of depression during pregnancy. Younger age and unemployment 
influences depression. This study provides an important step in documenting the need 
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for screening for antenatal depression in HIV associated pregnancies in a South African 
population group. 
 






Women represent approximately half (51%) of adults living with HIV infection 
worldwide 1; with the majority of infections occurring in women of reproductive age. 
Furthermore, the majority of women living with HIV globally are from Sub-Saharan 
Africa, and an estimated 1.5 million of these women become pregnant each year 2. In 
South Africa, one-fifth of women in their reproductive ages are HIV infected and recent 
HIV prevalence rates indicate that up to 22.8% of pregnant women are HIV infected 3. In 
the province of KwaZulu-Natal (KZN) alone, the antenatal rate of HIV infection is 
approximately 30% 4.  
 
Antenatal depression is a considerable health concern; having the potential to 
compromise the wellbeing of both mother and infant 5. Adverse outcomes include 
obstetric complications such as miscarriage, preterm labour, low birth weight babies 
and fetal growth restriction; as well a negative effect on the cognitive functioning of the 
mother 6.  
 
A diagnosis of HIV infection is accompanied by psychiatric distress, with depression 
being a common complication 7. A new HIV diagnosis increases this risk of depression 
in pregnancy 8. Depression in HIV infected pregnant women can negatively impact the 
adherence of antenatal regimes, which may aggravate disease progression 9, invariably 




The knowledge and timing of this diagnosis can also affect the development of 
depression. Studies found that women who are recently diagnosed with HIV infection 
are at a higher risk of depression; whilst women who know their HIV status before 
becoming pregnant were less likely to develop depressive symptoms 8. These symptoms 
were attributed to the relatively short time period for adjustment to the diagnosis, the 
stigma attached to being pregnant whilst HIV infected 5, as well as the fear of placing 
the unborn child at risk of HIV infection 6.  
 
However, it is controversial whether HIV infection impacts the frequency of depressive 
rates in pregnant women. Since KZN is considered to be the global epicentre of the HIV 
pandemic 4, its high prevalence rates of HIV in pregnancy and the likelihood of the 
burden of antenatal depression, we are well positioned to study the trio of HIV 
infection, depression and pregnancy. Thus the aim of this study is to compare 
depressive scores between newly diagnosed HIV infected and HIV uninfected pregnant 
women using the Edinburgh Depression Scale (EDS) in KZN to elucidate any 
association between a new diagnosis of HIV infection and the development of antenatal 
depression.  
 
Research methods and design 
Study design: A cross-sectional questionnaire based analysis of depressive scores in 




Study site and study population: From August to October 2016 a sample of 102 
pregnant women (62 HIV uninfected and 40 HIV infected) were recruited from 
antenatal clinics at two regional hospitals in KwaZulu-Natal, South Africa. Patients 
were recruited based on the study’s inclusion and exclusion criteria. Given the study 
design, only newly HIV tested women were included. Only Black South African women 
were included as there is a higher percentage of this population group attending these 
hospitals than other demographic groups. Additional inclusion criteria included being 
isiZulu speaking, and period of gestation (either second or third trimester). Pregnant 
women previously tested for HIV, non-Black South African patients and those that 
declined entry into the study were excluded. Furthermore, patients in the first trimester 
of pregnancy, those with medical and surgical complications, as well as individuals 
with a previous history of psychiatric illness were excluded.  
 
Data collection: While women waited for their routine antenatal appointment, the 
purpose and nature of the study was explained to the whole group by the research 
nurse. Research participants were then given individual patient information sheets in 
isiZulu and invited to participate. Socio-demographic and clinical data including 
maternal age, gestational age, parity, whether the pregnancy was planned or 
unplanned, area of residence, level of education, employment status, substance use, 
relationship status, HIV status, and CD4 cell counts were recorded on a structured data 
sheet and participants were then assessed for depressive symptomology using the 
Edinburgh Depression Scale (EDS). This 10-item self-report scale relates to an 
individual’s depressive symptoms during the past 7 days. Each item is scored on a 4-
point scale with a total score range of 0 – 30, where a higher score indicates greater 
distress. It focuses on the individuals cognitive and affective depressive symptoms, 
whilst omitting somatic symptoms which could be confounded by normal pregnancy-
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related changes. It was originally established in 1987 and named the Edinburgh 
Postnatal Depression Scale, as it was developed as a screening tool for postpartum 
depression 10. However, this scale is now also validated as a screening tool for 
depression during pregnancy 11, giving rise to a new nomenclature: the Edinburgh 
Depression Scale. It is an easily administered questionnaire, and has been previously 
validated in antenatal Black South African women 6, and specifically amongst newly 
diagnosed HIV-infected antenatal women in South Africa 12. The EDS was translated 
into an isiZulu version for the purpose of this study and then completed in the form of 
interviews by each participant with the assistance of a Zulu speaking research nurse. 
Given the cut-off score for likely depression, women who scored ≥13 were offered 
referrals to the psychiatric clinic at either hospital. 
 
Data analysis: Data was analysed using GraphPad Prism 5.00 for Windows 
(GraphPad Software, San Diego California USA) and STATA version 12 (StataCorp LP, 
College Station, Texas USA). Parametric tests were performed. Continuous variables 
were described in terms of means ± standard deviations, and categorical variables using 
their frequencies and percentages. T-tests were generated to examine the associations 
between categorical variables and depressive scores. Spearman’s Correlation 
Coefficients were generated to determine the association between continuous variables 
and depressive scores. Frequency distributions were also calculated. Statistical 
significance was determined by a p-value of < 0.05.  
 
Ethical consideration: Prior to the commencement of study activities, ethical 
approval (BE271/16) and permission to conduct the study at a large district and a 
tertiary referral hospital was obtained. All participants signed a written informed 
19 
 




Patient socio-demographic data: Background characteristics of study population 
are depicted in Table 1. Maternal age of the sample ranged from 17 to 40 years, with a 
mean ± standard deviation of 25 ±5.30 years. More than two thirds of the participants 
had completed secondary school education (62.5% HIV-infected versus 69.4% HIV-
uninfected); unemployment rate was high across the sample, with 70% for HIV-infected 
versus 80.6% for HIV-uninfected women. The majority of women were single (90% - 
HIV-infected versus 93.6% - HIV-uninfected); whilst 80% of HIV-infected and 87.1% of 
HIV-uninfected women had not planned to fall pregnant. Of the 102 women, 14.7% 
reported having miscarriages in previous pregnancies, with more cases reported in the 





















n (%) or mean ± SD 
Age (years) 28(4.86) 22(2.83) 
Gestational age (weeks) 18(5.31) 20(5.75) 
Planned pregnancy (%) 
  Yes 8(20) 8(12.90) 
No 32(80) 54(87.10) 
Area of residence (%) 




Highest level of education (%) 
  No formal education 1(2.5) 0(0) 
Primary school 1(2.5) 0(0) 
Secondary school 25(62.5) 43(69.4) 
University 13(32.5) 19(30.6) 
Employment status (%) 
  Employed 12(30) 12(19.4) 
Unemployed 28(70) 50(80.6) 
Relationship status (%) 
  Single 36(90) 58(93.6) 
Married 4(10) 4(6.4) 
CD4 cells count (cells/mm3) 425(165.25) 0(0) 
 
Age, gestational age and CD4 cell counts are presented as mean ± SD (Standard deviations). 
Planned pregnancy, area of residence, level of education, employment status and 
relationship status are presented as frequencies (n) and percentages (%). 
 
Prevalence and correlates of depression: Evaluation of the EDS demonstrated a 
Cronbach’s alpha of 0.76. As shown in Figure 1, of the sample of 102 women, 10 (9.80%) 
had an EDS score of ≥13, indicating probable depression; majority falling within the 
HIV-infected cohort (7.8%) and 18.6% of HIV-infected women displayed symptoms of 
significant distress. No depression was reported by 50% of HIV-uninfected women. 
Analysis among women’s total depressive scores from the EDS, irrespective of 
depressive severity, showed a significant association between depression and HIV 
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status and maternal age, which are further highlighted in figures 3 and 4 respectively. 
The total depressive scores differed significantly between HIV-infected (M=10.43, 
SD=3.46, n=40, 95% CI: 9.317393-11.53261) and the HIV-uninfected (M=6.77, SD=3.13, 
n=62, 95% CI: 5.979836-7.568551) women (p<0.0001). HIV-infected women were more 
prone to higher scores on the EDS than HIV-uninfected women (t= -5.52, df=100). Total 
depressive scores differed significantly with maternal age of women at the 0.05 level of 
significance, indicating that younger women were more inclined to higher scores of 
depression (r=0.21; p=0.03). There were no significant correlations between level of 
education (p=0.55); whether pregnancy was planned or not (p=0.87); relationship status 
(p=0.65); CD4 cell count (p=0.69) and severity of depressive scores. There was a trend 
association between employment status and total depressive scores (p=0.09). 
Unemployed women (M=8.55; SD=3.34; n=78; 95% CI: 7.80-9.30) were more depressed 
than employed women (M=7.08; SD=4.61; n=24; 95% CI: 5.13-9.03).  
 
 
Figure 1. Prevalence of depressive symptoms among 102 newly diagnosed HIV-infected and 
HIV-uninfected pregnant women in KwaZulu-Natal, South Africa. No depression: EDS 
scores of 0 to 9; significant distress: EDS scores of 10 to 12; probable depression: EDS scores 















HIV Negative HIV Positive
1 - No depression
2 - Significant distress





























Figure 2. Depressive scores of HIV-infected vs HIV-uninfected pregnant women. Results are 
presented as mean ± standard deviations. *** Total depressive scores differed significantly 
between the HIV-infected and HIV-uninfected cohorts, p<0.0001.  
 
 
Figure 3. Correlation between maternal age and total depressive scores on the EDS. The red 
line represents the cut-off score for probable depression (13) on the EDS.*Total depressive 
scores differed significantly with maternal age of women, p=0.03. 




























Key findings: A new diagnosis of HIV infection during pregnancy can affect the 
severity of depressive scores. In this study we used the EDS to evaluate the prevalence 
and severity of depressive scores in newly diagnosed HIV-infected and HIV-uninfected 
pregnant women in order to elucidate the role of a new diagnosis of HIV infection in 
the development of depression.  
 
We report a low prevalence rate of depression regardless of HIV status across the study 
population. Notably, the majority of women displaying scores consistent with 
depression were from the HIV-infected cohort. However, when only considering 
women with probable depression (equivalent to a score of ≥13), no significant difference 
in the prevalence of depression between the HIV-infected compared to the HIV-
uninfected cohorts were found (p=0.79). 
 
Moreover, our study reports that women’s total depressive scores, irrespective of 
depressive severity was significantly different between HIV-infected and uninfected 
pregnant women. Higher depressive scores were demonstrated in the HIV-infected 
cohort, highlighting that a new diagnosis of HIV infection predisposes a pregnant 
women to a greater risk of developing depression. Interestingly, among the HIV-
infected cohort of our study, the majority of women displayed significant distress rather 
than probable or severe depression. This was also highlighted in other studies which 
found a diagnosis of HIV infection to increase the risk and severity of emotional distress 
in pregnant women 13. 
A significant difference in maternal age was noted between the study cohorts. HIV-
infected pregnant women were much older than HIV-uninfected pregnant women. 
Additionally we found that as maternal age increased, the level of depression 
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decreased, demonstrating that younger women were more inclined to develop 
depression.  
 
Also as expected, unemployed pregnant women were more depressed than employed 
women. Although only borderline significant (p=0.09), an unemployed status was noted 
to have a minor effect on severity of depressive scores. 
 
Discussion of key findings: Our study demonstrates that 9.8% of pregnant women 
displayed symptoms of depression, irrespective of HIV status. This rate of depression 
contradicts previous literature in which higher prevalence rates of depression were 
found in similar settings: 38.5% in urban KZN and 47% in rural KZN 6, 12. Our low rate 
of depression may be attributed to South Africa’s shift to a low-middle income country, 
in which prevalence of antenatal depression (15.6%) are similar to our study 14. This was 
corroborated by the fact that 95% of women in our sample resided in urban areas and 
that the majority of women had a moderate-high level of education. Furthermore, the 
gestational periods at which women were recruited differed with previous studies, 
which could further explain our low prevalence of depression 8, 15. 
 
We report that total depressive scores on the EDS, irrespective of depressive severity, 
differed significantly between the HIV-infected and uninfected cohort. This finding is 
not novel and evidence of elevated depressive scores among HIV-infected pregnant 
women have been previously reported 6. It is possible that in our group, because we 
interviewed only newly diagnosed pregnant women, these results may be attributed to 
an adjustment reaction to the recent report of a positive HIV diagnosis. Analogous 
evidence supporting this hypothesis have been noted previously 5. Nevertheless, our 
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finding suggests that a new diagnosis of HIV-infection in pregnancy increases the 
development of depression. 
 
However, we did not find a difference in prevalence rates of depression between the 
HIV-infected and HIV-uninfected cohorts. Similar findings were reported in HIV-
infected and uninfected pregnant women in South Africa and USA 12, 16. Yet, our finding 
contradicts other reports, in which prevalence of depression was significantly greater 
among HIV-infected pregnant women 6, 8. Our finding might be explained by the 
province’s high HIV prevalence rate, which has destigmatised the disease, thus making 
a diagnosis of HIV infection more acceptable. Additionally accessibility to antiretroviral 
therapy and medical regimes has improved in South Africa, and has led to decreased 
mortality by slowing the progression of HIV to full-blown AIDS; thus shifting the status 
of a HIV infection from a death sentence to a chronic illness, may also be a factor 
explaining these findings. Similar correlations are also evident in other studies, in which 
the idea of HIV infection as a chronic disease has made a diagnosis increasingly 
normalised 17.  
 
Maternal age is a predictor of depression, indicating that younger women are at a 
greater risk of developing depression than older women 15. Our results corroborate 
these findings, in that younger maternal age was associated with a higher level of 
depression. The analogous rates of depression between both cohorts may be further 
explained by the increased maternal age of the HIV-infected cohort. 
 
Unemployed women were at a greater risk of developing depression than employed 
women in this study. This may be elucidated by the increased financial and social 
support one receives when having a permanent job. This finding has been 
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demonstrated previously 14, and is evidence that socio-economic circumstances 
contribute to the development and severity of depression.  
 
In contrast to previous reports we were unable to demonstrate correlations between 
level of education; planned pregnancy; relationship status and CD4 cell counts 6, 18. With 
regard to education and relationship status, failure to attain any significant difference in 
our study may be due to the unequal sample size between the study cohorts and the 
majority of women falling within the secondary school and single categories 
respectively. Although other studies have found lower CD4 cell counts to be associated 
with higher rates of depression 18, our study did not find any difference in depressive 
rates according to CD4 cell count.  
 
Strengths and limitations: This study reports and compares depressive scores of 
newly diagnosed HIV-infected and HIV-uninfected pregnant women in KZN, South 
Africa. It provides valuable information on the prevalence; as well as the role played by 
HIV-infection and other sociodemographic and clinical data as risk factors for 
depression in pregnant women, in a province that is the foremost contributor to the 
global HIV pandemic. The EDS also demonstrated good internal reliability, with a 
Cronbach’s alpha of 0.76, indicating that women in this study were consistent in their 
response. 
 
Our study has limitations. One is the relatively small sample size, accompanied by the 
unequal sample size between cohorts. The study population was limited to Black 
African women, therefore it is not known whether the results can be generalizable to 
other populations. Furthermore, certain variables noted in previous studies that were 
found to be associated with depression were not assessed in the current study. Finally, 
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the cross-sectional design of the study limits us to mere associations and prevents actual 
causal inferences. 
 
Recommendations: Given the likelihood of the burden of antenatal depression on 
the quality of life of both mother and infant, future studies conducting research on a 
larger sample involving all three trimesters of pregnancy and following delivery are 
recommended. 
 
Conclusion: We report a low prevalence of depression in pregnancy, irrespective of 
HIV status, which may be attributed to the improved perception of HIV infection in 
South Africa. Additionally we report that a new diagnosis of HIV infection in 
pregnancy exacerbates the risk for the development of depression. Moreover, we 
demonstrate that younger maternal age and unemployment increases the development 
of depression. Furthermore, we report similar rates of depression between HIV-infected 
and uninfected cohorts. This study provides an important step in documenting the need 
for screening for antenatal depression across all three trimesters and following delivery 
in HIV associated pregnancies. 
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The prevalence rate of Human Immunodeficiency Virus (HIV) infection in KwaZulu-Natal Province 
is high (Department of Health, 2012), with a significant amount of those infected being women of 
reproductive age (Kalumba et al., 2013). A diagnosis of HIV infection can result in negative 
psychological outcomes and has been associated with an augmented risk for the development of 
depression (Kotze et al., 2013; Tate et al., 2003; Psaros et al., 2009; Manikkam and Burns, 2012). A 
diagnosis of depression is a serious health concern; antenatal depression even more so, as it has the 
potential to cause wide-reaching adverse consequences for both the mother and the unborn child 
(Psaros et al., 2009). These include obstetric complications and poor birth outcomes, such as 
miscarriage, preterm labour and fetal growth restriction, as well as an increased risk for the 
development of postnatal depression (Alder et al., 2007; Marcus, 2009). In addition to the 
physiological effects associated with antenatal depression, it may also affect the cognitive 
functioning of a woman, thus altering decision-making capabilities (Manikkam and Burns, 2012).  
 
With a diagnosis of HIV infection in pregnancy, the negative effects of antenatal depression on a 
women’s cognitive functioning and decision-making capabilities can deter proper attendance and the 
following of antenatal anti-retroviral regimes; leading to an increase in disease progression, further 
affecting both mother and child (Manikkam and Burns, 2012; Antelman et al., 2007). Despite this 
fact, limited data on the prevalence of antenatal depression among the HIV-infected population are 
available, and it is still controversial whether a diagnosis of HIV infection has an impact on the 
frequency of depressive rates in pregnant women. Thus this study compares depressive scores 
between newly diagnosed HIV-infected and uninfected pregnant women in KwaZulu-Natal using the 
Edinburgh Depression Scale (EDS) to determine if there is an association between a new diagnosis of 
HIV infection and the development of antenatal depression. 
 
In our study, we found that irrespective of HIV status, only 9.8% of pregnant women displayed 
symptoms of depression. These results are in contrast to previous reports which found a greater 
prevalence of antenatal depression in similar settings: 38.5% in urban KwaZulu-Natal; 39% in Cape 
Town; 41%-47% in rural KwaZulu-Natal; and 48.7% in Mpumalanga (Manikkam and Burns, 2012; 
Hartley et al., 2011; Rochat et al., 2006; Rochat et al., 2013; Peltzer et al., 2016 ). The low rate of 
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depression observed in our study is similar to those found in other low-middle income countries 
(Fisher et al., 2012), which may be attributed to the fact that South Africa is no longer considered a 
developing country. Moreover, 95% of women in our study population resided in urban areas and the 
level of education completed by the majority of women was moderate to high, further highlighting 
this fact. Additionally, the gestational periods at which women were recruited for our study differed 
from other studies, and could also account for the dramatic differences in prevalence rates of 
depression (Manikkam and Burns, 2012; Ayele et al., 2016). Consequently, more research involving 
all trimesters of pregnancy are warranted. Nevertheless, the EDS screening tool in our study 
demonstrated good internal reliability, with a Cronbach’s alpha of 0.76, indicating that women in this 
study were consistent in their response. Notably, the strength of our findings is the fact that we 
focused on a new diagnosis of HIV infection, before the initiation of anti-retroviral (ARV) treatment. 
 
Our study did not demonstrate a difference in the prevalence of depression between the HIV-infected 
and HIV-uninfected cohorts. Similar findings were reported in HIV-infected and uninfected pregnant 
women in South Africa (low-middle income) and the USA (middle-high income), wherein a 
diagnosis of HIV infection did not predispose the development of depression (Rochat et al., 2006; 
Rubin et al., 2011; Bonacquisti et al., 2014). Yet, this finding is contradictory to other reports of 
elevated rates of depression in HIV-infected pregnant women (Kwalomota et al., 2002; Olley et al., 
2004; Whetten et al., 2008; Ramirez-Avila et al., 2012; Manikkam and Burns, 2012; Natamba et al., 
2014).  
 
Given that the province of KwaZulu-Natal is considered to be the epicentre of the global HIV 
pandemic (Department of Health, 2012), a diagnosis of HIV infection is a common occurrence. 
Support structures are high and the disease has been significantly destigmatised, making a diagnosis 
of HIV-infection less traumatic. These factors may account for the low prevalence in our study. 
Furthermore, the accessibility to ARV therapy and medical regimes in South Africa particularly for 
pregnant women has improved tremendously over the years, leading to decreased mortality rates by 
slowing down the progression of HIV to full-blown AIDS. This has resulted in the shift of the status 
of a diagnosis HIV infection from a death sentence to a chronic illness, which might also be a factor 
contributing to our findings. The normalisation of a diagnosis of HIV infection due to its chronicity 
was also evident in other studies (Letteney and Heft LaPorte, 2004; Deeks et al., 2013).  
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Maternal age is a predictor of depression, indicating that younger women are at a greater risk of 
developing depression than older women. (Ayele et al., 2016; Koleva et al., 2011). Our results 
corroborate these findings, in that younger maternal age was associated with a higher level of 
depression. The analogous rates of depression between both cohorts may be further explained by the 
increased maternal age of the HIV-infected cohort.  
 
However, when evaluating overall depressive scores on the EDS, irrespective of depressive severity, 
we found that scores differed significantly between the HIV-infected and uninfected cohorts. Higher 
depressive scores were noted among the HIV-infected cohort. This result is not novel and evidence 
of elevated depressive scores among HIV-infected pregnant women have been previously reported 
(Rochat et al., 2006 and Manikkam and Burns, 2012). Since we interviewed only newly diagnosed 
HIV-infected women in this study, it is possible that these results may be attributed to only an 
adjustment reaction to the recent report of a positive diagnosis. Similar data substantiating this 
hypothesis have been noted previously (Lyketsos et al., 1994; Psaros et al., 2009). Nevertheless, our 
finding suggests that a new diagnosis of HIV-infection in pregnancy increases the development of 
depression. 
 
We also demonstrated that unemployed women in both cohorts displayed elevated scores consistent 
with significant distress and probable depression on the EDS. These finding are corroborated (Fisher 
et al., 2012; Peltzer et al., 2016; Olley et al., 2004; Manikkam and Burns, 2012), and is evidence that 
an individual’s socio-economic circumstances may play a role in the development and severity of 
depression.  
 
In contrast to our findings, the level of education; planned pregnancy; relationship status and CD4 
cell counts are found to be risk factors for the development of depression (Manikkam and Burns, 
2012; Kapetanovic et al., 2009). With regard to education and relationship status, failure to attain any 
significant difference may be due to the fact that the majority of women in our study fell within the 
secondary school and single categories respectively. Nevertheless, this study highlights the high rate 
of unplanned pregnancies found in this country. However, this was not found to be a risk factor for 
the development of depression. Additionally, although other studies have found lower CD4 cell 
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counts to be associated with elevated rates of depression (Kapetanovic et al., 2009), we did not find 
any difference in depressive rates in our population stratified by CD4 cell count.  
 
As far as we are aware this study is only one of the few studies to report and compare the depressive  
scores of newly diagnosed HIV-infected and HIV-uninfected pregnant women in KwaZulu-Natal, 
South Africa. This study provides valuable information on the prevalence; as well as the role played 
by HIV-infection and other sociodemographic and clinical data as risk factors for the development of 
depression in pregnant women, in a province that is the foremost contributor to the global HIV 
pandemic. Additionally our methodological tool used for the assessment of depressive 
symptomology- the EDS, displayed good internal reliability in this study. 
 
Limitations of this study include, the relatively small sample size, accompanied by the unequal 
sample size between cohorts. Additionally the study population was limited to Black African women, 
therefore it may not be generalizable to other populations. Finally, the cross-sectional design of the 
study limits causal inferences.  
 
In conclusion, this study reports a low prevalence of depression across the study population. Similar 
rates of depression were found between the HIV-infected and HIV-uninfected cohorts. Nevertheless, 
our findings indicate that a new diagnosis of HIV infection in pregnancy places a woman at risk for 
the development of depression, exacerbating antenatal depression. This study also demonstrates that 
younger maternal age and unemployment elevates antenatal depression. Given the likelihood of the 
burden of antenatal depression on the quality of life of mother and infant, future studies conducting 
research on a larger sample involving all three trimesters of pregnancy and following delivery are 
recommended. This study provides a vital step in documenting the need for screening for antenatal 
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                                                  Downloadable version  
EDINBURGH DEPRESSION SCALE*   
Also known as the Edinburgh Postnatal Depression Scale (EPDS)*  
  
Today’s Date:  _____/_____/_____ Weeks pregnant: _____or weeks postnatal _______                        
                                                                                                                                           TOTAL  
Surname: _________________________Given Name(s): ________________            SCORE  
  
INSTRUCTIONS:  
Please colour in one circle for each question that is the closest to how you have felt in the PAST SEVEN DAYS.   
  
1. I have been able to laugh and see the funny side of 
things:  
○ As much as I always could  
○ Not quite as much now  
○ Definitely not so much now  
○ Not at all  
6. Things have been getting on top of me: 
○ Yes, most of the time I haven’t been able to cope at all  
○ Yes, sometimes I haven’t been coping as well as usual  
○ No, most of the time I have coped quite well 
○ No, I have been coping as well as ever  
2. I have looked forward with enjoyment to things:  
○ As much as I ever did  
○ Rather less than I used to  
○ Definitely less than I used to  
○ Hardly at all 
7. I have been so unhappy that I have had difficulty      
sleeping:  
○ Yes, most of the time  
○ Yes, sometimes  
○ Not very often  
○ No, not at all  
3. I have blamed myself unnecessarily when things      
went wrong:  
○ Yes, most of the time  
○ Yes, some of the time  
○ Not very often  
○ No, never  
8. I have felt sad or miserable:  
○ Yes, most of the time  
○ Yes, quite often  
○ Not very often  
○ No, not at all  
4. I have been anxious or worried for no good      
reason:  
○ No, not at all  
○ Hardly ever  
○ Yes, sometimes  
○ Yes, very often  
9. I have been so unhappy that I have been crying:  
○ Yes, most of the time  
○ Yes, quite often  
○ Only occasionally 
○ No, never  
5. I have felt scared or panicky for no very 
good reason:  
○ Yes, quite a lot 
○ Yes, sometimes 
○ No, not much 
○ No, not at all 
10. The thought of harming myself has occurred to me: 
○ Yes, quite often 
○ Sometimes 
○ Hardly ever 
○ Never 
            Comments: ________________________________________________________________________  
                                 ________________________________________________________________________  
                                 * Murray and Cox 1990           * Cox, Holden & Sagovsky  1987 
  
NB: If you have had ANY 
thoughts of harming 
yourself, please tell your 




INGXENYE YESIBILI- (uhla) 
EDINBURG DEPRESSION SCALE 
Lubizwa futhi nge- Edinburgh Postnatal Depression Scale (EPDS). 
 
Usuku: ____/_____/_____ Amasonto ukhulelwe: ____________ Noma amasonto ubelethile: _____ 
 
         SEKUHLANGENE  
 
Sicela uhlikihle kwisikokela esisodwa embuzweni ngamunye osondelene kakhulu nokuthi ubuzizwa unjani ezinsukwini 
EZIYISIKHOMBISA EZEDLULE. 
 
1. Bengikwazi ukuhleka futhi ngibone nokuhlekisa 
kwaleyonto: 
○ Njengoba bekuhlale kwenzeka  
○ Akusenzeki njengoba bekwenzeka 
○ Akusenzeki kakhulu  
○ Akusenzeki kwakhona 
 
6. Izinto ziqale ukubanzima kimi: 
○ Yebo, isikhathi esiningi bengingakwazi nokumela isimo 
○ Yebo, kwesinye isikhathi bengingakwazi nokumela isimo 
njengoku-jwayelekile 
○ Cha, isikhathi esiningi bengikwazi ukumela isimo 
ngendlela eyiyo 
○ Cha, bengikwazi ukumela isimo kahle njengasekuqaleni 
 
2. Ngikwazile ukuqhubeka nezinto ezingijabulisayo: 
○ Njengoba bekuvele kwenzeka  
○ Kwehlile kancane kunokujwayelekile/ obekwenzeka 
○ Kwehlile kakhulu kunokujwayelekile 
○ Sekunzina kakhulu  
 
7. Bengingajabule kangangoba bengisasakwazi nokulala 
kahle: 
○ Yebo, isikhathi esiningi  
○ Yebo, kwesinye isikhathi 
○ Cha, bekungenzeki njalo 
○ Cha, akukaze kwenzeke 
 




3. Benginokuzisola okungenasidingo uma izinto 
zingahambanga kahle: 
○ Yebo, isikhathi esiningi  
○ Yebo, isikhathi esiningana 
○ Cha, bekungenzeki njalo 
○ Cha, bekungeneki  
 
8. Bengizizwa ngiphatheke kabi noma kungathi 
ngilahliwe: 
○ Yebo, isikhathi esiningi  
○ Yebo, isikhathi esiningana 
○ Cha, bekungenzeki njalo 
○ Cha, akukaze kwenzeke 
 
4. Benginokudinwa noma ngiphatheke kabi 
kungenasizathu: 
○ Cha, akukaze kwenzeka 
○ Bekuthuka kwenzeka nje 
○ Yebo, kwesinye isikhathi 
○ Yebo, isikhathi esiningi 
 
9. Bengingajabule ngendlela yokuthi bengikhala: 
○ Yebo, isikhathi esiningi 
○ Yebo, isikhathi esiningana 
○ Bekuba yilesosikhathi nje 
○ Cha, akukaze kwenzeke 
 
5. Bengizizwa ngisaba noma ngitatazela kungenasizathu: 
○ Yebo, isikhathi esiningi impela 
○ Yebo, kwesinye isikhathi 
○ Cha, bekungenzeki kakhulu 
○ Cha, bekungenzeki kwakhona 
 
10. Imicabanago yokuzilimaza ike yafika kimi: 
○ Yebo, isikhathi esiningana  
○ Kwesinye isikhathi 
○ Ibifika nje ngalesosikhathi 






           Comments: ________________________________________________________________________ 
                                 ________________________________________________________________________ 
                                 * Murray and Cox 1990           * Cox, Holden & Sagovsky  1987 
Kubalulekile: Uma uke waba nanoma 
yimiphi imicabango yokuzilimaza, sicela 
ubikele udokotela noma umbelethisi 
namhlanje 
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